• "Signal" Enables Malarial Parasites to Target Blood Cell
    Northwestern University researchers have identified a key molecular “signal” that allows malarial parasites to release virulence proteins inside human red blood cells. The investigators, led by Kasturi Haldar and N. Luisa Hiller, also found that the process by which the ...More
    December 10, 2004 Posted in News, PPE & Standard Precautions
  • CDC Issues Draft TB Prevention Guidelines for Public Comment
    The Centers for Disease Control and Prevention (CDC) has published a notice in the Federal Register requesting public comments on draft revised guidelines titled, "Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005." The ...More
    December 9, 2004 Posted in News
  • GlaxoSmithKline Announces Phase III Clinical Trial for Fluarix
    PHILADELPHIA -- GlaxoSmithKline (GSK) announced the launch of a pivotal trial with its investigational influenza vaccine, Fluarix, in partnership with the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. National Institutes of Health ...More
    December 9, 2004 Posted in News
  • Dynavax Announces Positive Interim Results from Phase II/III Hepatitis B Vaccine Trial
    BERKELEY, Calif. -- Dynavax Technologies announced that data from an interim analysis of the company's hepatitis B virus (HBV) vaccine phase II/III clinical trial showed statistically significant superiority in protective antibody response and robustness of protective ...More
    December 9, 2004 Posted in News
  • Nabi Biopharmaceuticals Continues to Make Important Progress with StaphVAX(R) Development Program
    ROCKVILLE, Md. -- Nabi Biopharmaceuticals announced that the company's StaphVAX(R) (Staphylococcus aureus Polysaccharide Conjugate Vaccine) continues to be on track towards achieving two important development milestones: First, filing its Marketing Authorization Application ...More
    December 9, 2004 Posted in News
  • Aethlon Medical Releases Smallpox-Related Data
    SAN DIEGO -- Aethlon Medical, Inc. announced its scientists have completed initial non-clinical human blood studies which indicate that the Hemopurifier(TM) treatment technology is effective in capturing smallpox-related viruses from human blood. The studies documented that ...More
    December 9, 2004 Posted in News
  • New Antibiotic Target Could Mean the End of Pneumonia
    Scientists have found a “molecular Achilles’ heel” in the organism that causes pneumonia, providing a target for the development of a new class of antibiotics that could eventually eradicate the disease. Their report is scheduled to appear in the Dec. 28 edition of ...More
    December 9, 2004 Posted in News
  • ARMP Documents Trends in Antimicrobial Susceptibility
    How can a hospital tell if a commonly used antibiotic is showing activity against a bacterial infection within its institution? By participating in the Antimicrobial Resistance Management Program (ARMP), a project of the University of Florida. ARMP, an ongoing national ...More
    December 9, 2004 Posted in News
  • Avian Influenza Resource Web Site Posted
    University of Maryland avian influenza virus researcher Daniel Perez has posted a comprehensive Web site that offers information about the influenza A virus and describes his Avian Influenza Virus Program - http://www.agnr.umd.edu/avianflu/ Perez, assistant professor of ...More
    December 9, 2004 Posted in News
  • Screening for Genital Herpes Should be Targeted
    ALEXANDRIA, Va. -- Identifying asymptomatic people with genital herpes infection through targeted screening of high-risk groups may prevent disease transmission. However, widespread screening of pregnant women is unlikely to reduce the occurrence of herpes in newborns, ...More
    December 9, 2004 Posted in News